These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35283314)

  • 1. Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii.
    Zhao J; Zhu Y; Lin YW; Yu H; Wickremasinghe H; Han J; Velkov T; McDonald MJ; Li J
    Clin Microbiol Infect; 2022 Jul; 28(7):1026.e1-1026.e5. PubMed ID: 35283314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii.
    Zhao J; Zhu Y; Han ML; Lu J; Yu HH; Wickremasinghe H; Zhou QT; Bergen P; Rao G; Velkov T; Lin YW; Li J
    Int J Antimicrob Agents; 2023 Sep; 62(3):106902. PubMed ID: 37380093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
    J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.
    Girardello R; Visconde M; Cayô R; Figueiredo RC; Mori MA; Lincopan N; Gales AC
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):37-44. PubMed ID: 27776788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii.
    Lim TP; Ong RT; Hon PY; Hawkey J; Holt KE; Koh TH; Leong ML; Teo JQ; Tan TY; Ng MM; Hsu LY
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7899-902. PubMed ID: 26438500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Kim SY; Seo HW; Park MS; Park CM; Seo J; Rho J; Myung S; Ko KS; Kim JS; Ryu CM
    J Antimicrob Chemother; 2023 Apr; 78(4):923-932. PubMed ID: 36880170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.
    Zhao J; Han ML; Zhu Y; Lin YW; Wang YW; Lu J; Hu Y; Tony Zhou Q; Velkov T; Li J
    Biochem Pharmacol; 2021 Feb; 184():114400. PubMed ID: 33387481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
    Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.
    Cheah SE; Johnson MD; Zhu Y; Tsuji BT; Forrest A; Bulitta JB; Boyce JD; Nation RL; Li J
    Sci Rep; 2016 May; 6():26233. PubMed ID: 27195897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
    Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates.
    Barin J; Martins AF; Heineck BL; Barth AL; Zavascki AP
    Ann Clin Microbiol Antimicrob; 2013 Jul; 12():15. PubMed ID: 23819554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin B Heteroresistance and Adaptive Resistance in Multidrug- and Extremely Drug-Resistant Acinetobacter baumannii.
    Genteluci GL; de Souza PA; Gomes DBC; Sousa VS; de Souza MJ; Abib JRL; de Castro EAR; Rangel K; Villas Bôas MHS
    Curr Microbiol; 2020 Sep; 77(9):2300-2306. PubMed ID: 32494882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.
    Arroyo LA; Herrera CM; Fernandez L; Hankins JV; Trent MS; Hancock RE
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3743-51. PubMed ID: 21646482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.
    Li Y; Wang B; Lu F; Ahn J; Zhang W; Cai L; Xu J; Yin Y; Cao Q; Ren Z; He X
    Microbiol Spectr; 2022 Feb; 10(1):e0176821. PubMed ID: 35196792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel decoy strategy for polymyxin resistance in
    Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
    Elife; 2021 Jun; 10():. PubMed ID: 34180396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating virulence features of Acinetobacter baumannii resistant to polymyxin B.
    de Souza CM; Silvério de Oliveira W; Fleitas Martínez O; Dos Santos Neto NA; Buccini DF; Nieto Marín V; de Faria Júnior C; Rocha Maximiano M; Soller Ramada MH; Franco OL
    Lett Appl Microbiol; 2024 Jul; 77(7):. PubMed ID: 38942450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
    Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.